FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085191137> ?p ?o ?g. }

• W2085191137 abstract "Early induction with biologics can reduce complications in patients with Crohn’s disease (CD) and improve their quality of life. The safety of biologics, however, is uncertain. Granulocyte and monocyte adsorptive apheresis (GMAA) is a natural biologic therapy that selectively removes granulocytes and monocytes/macrophages and has few severe adverse effects. The effects of GMAA on patients with early-diagnosed CD are unclear. We investigated the effects of GMAA combined with thiopurines on patients with early-diagnosed CD. Twenty-two corticosteroid- and biologic-naïve patients with active early-diagnosed CD were treated with intensive GMAA (twice per week) combined with thiopurines administration. Active early-diagnosed CD was defined as follows: (i) within 2years after diagnosis of CD, (ii) with no history of both surgical treatment and endoscopic dilation therapy, and (iii) Crohn’s Disease Activity Index (CDAI) was higher than 200. We investigated the ratios of clinical remission defined as CDAI was less than or equal to 150 at 2, 4, 6 and 52weeks and mucosal healing defined as a Simplified Endoscopic Activity Score for Crohn’s Disease (SES-CD) as 0 at 6 and 52weeks. Adverse events were recorded at each visit. The ratios of clinical remission at 2, 4, and 6 weeks were 6 of 22 (27.2%), 12 of 22 (54.5%), and 17 of 22 (77.2%), respectively. At 52 weeks, 18 of 21 patients (81.8%) were in clinical remission. The ratios of mucosal healing at 6 and 52 weeks were 5 of 22 (22.7%) and 11 of 22 (50%), respectively. The difference in the mucosal healing ratio was significant between 6 and 52 weeks (p = 0.044). No serious adverse effects were observed during this study. Combination therapy with intensive GMAA and thiopurines administration rapidly induced high remission in patients with active early-diagnosed CD without serious adverse effect. Mucosal healing was observed in 50.0% of enrolled patients. This combination therapy might be a rational option for patients with early-diagnosed CD." @default.
• W2085191137 created "2016-06-24" @default.
• W2085191137 creator A5002391399 @default.
• W2085191137 creator A5002820431 @default.
• W2085191137 creator A5005842212 @default.
• W2085191137 creator A5007840193 @default.
• W2085191137 creator A5031080844 @default.
• W2085191137 creator A5042293515 @default.
• W2085191137 creator A5047963364 @default.
• W2085191137 creator A5050010393 @default.
• W2085191137 creator A5051804635 @default.
• W2085191137 creator A5062748030 @default.
• W2085191137 creator A5073672829 @default.
• W2085191137 date "2014-07-11" @default.
• W2085191137 modified "2023-10-09" @default.
• W2085191137 title "Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease" @default.
• W2085191137 cites W1489583234 @default.
• W2085191137 cites W1752248076 @default.
• W2085191137 cites W1761355724 @default.
• W2085191137 cites W1972859597 @default.
• W2085191137 cites W1977554333 @default.
• W2085191137 cites W1987974049 @default.
• W2085191137 cites W1996981713 @default.
• W2085191137 cites W1997402233 @default.
• W2085191137 cites W2000368489 @default.
• W2085191137 cites W2003492229 @default.
• W2085191137 cites W2010469688 @default.
• W2085191137 cites W2030638936 @default.
• W2085191137 cites W2043258441 @default.
• W2085191137 cites W2045402066 @default.
• W2085191137 cites W2071662837 @default.
• W2085191137 cites W2081134502 @default.
• W2085191137 cites W2083908345 @default.
• W2085191137 cites W2087461697 @default.
• W2085191137 cites W2098638622 @default.
• W2085191137 cites W2123463178 @default.
• W2085191137 cites W2126807394 @default.
• W2085191137 cites W2131632358 @default.
• W2085191137 cites W2143904760 @default.
• W2085191137 cites W2145436896 @default.
• W2085191137 cites W2152381563 @default.
• W2085191137 cites W2154117979 @default.
• W2085191137 cites W2167152940 @default.
• W2085191137 cites W3149527659 @default.
• W2085191137 doi "https://doi.org/10.1186/1471-230x-14-124" @default.
• W2085191137 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4105052" @default.
• W2085191137 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25015328" @default.
• W2085191137 hasPublicationYear "2014" @default.
• W2085191137 type Work @default.
• W2085191137 sameAs 2085191137 @default.
• W2085191137 citedByCount "13" @default.
• W2085191137 countsByYear W20851911372015 @default.
• W2085191137 countsByYear W20851911372016 @default.
• W2085191137 countsByYear W20851911372017 @default.
• W2085191137 countsByYear W20851911372018 @default.
• W2085191137 countsByYear W20851911372020 @default.
• W2085191137 countsByYear W20851911372021 @default.
• W2085191137 countsByYear W20851911372022 @default.
• W2085191137 countsByYear W20851911372023 @default.
• W2085191137 crossrefType "journal-article" @default.
• W2085191137 hasAuthorship W2085191137A5002391399 @default.
• W2085191137 hasAuthorship W2085191137A5002820431 @default.
• W2085191137 hasAuthorship W2085191137A5005842212 @default.
• W2085191137 hasAuthorship W2085191137A5007840193 @default.
• W2085191137 hasAuthorship W2085191137A5031080844 @default.
• W2085191137 hasAuthorship W2085191137A5042293515 @default.
• W2085191137 hasAuthorship W2085191137A5047963364 @default.
• W2085191137 hasAuthorship W2085191137A5050010393 @default.
• W2085191137 hasAuthorship W2085191137A5051804635 @default.
• W2085191137 hasAuthorship W2085191137A5062748030 @default.
• W2085191137 hasAuthorship W2085191137A5073672829 @default.
• W2085191137 hasBestOaLocation W20851911371 @default.
• W2085191137 hasConcept C126322002 @default.
• W2085191137 hasConcept C197934379 @default.
• W2085191137 hasConcept C203014093 @default.
• W2085191137 hasConcept C2776738589 @default.
• W2085191137 hasConcept C2778260677 @default.
• W2085191137 hasConcept C2779134260 @default.
• W2085191137 hasConcept C2779280984 @default.
• W2085191137 hasConcept C2781184567 @default.
• W2085191137 hasConcept C41260117 @default.
• W2085191137 hasConcept C71924100 @default.
• W2085191137 hasConcept C89560881 @default.
• W2085191137 hasConcept C90924648 @default.
• W2085191137 hasConceptScore W2085191137C126322002 @default.
• W2085191137 hasConceptScore W2085191137C197934379 @default.
• W2085191137 hasConceptScore W2085191137C203014093 @default.
• W2085191137 hasConceptScore W2085191137C2776738589 @default.
• W2085191137 hasConceptScore W2085191137C2778260677 @default.
• W2085191137 hasConceptScore W2085191137C2779134260 @default.
• W2085191137 hasConceptScore W2085191137C2779280984 @default.
• W2085191137 hasConceptScore W2085191137C2781184567 @default.
• W2085191137 hasConceptScore W2085191137C41260117 @default.
• W2085191137 hasConceptScore W2085191137C71924100 @default.
• W2085191137 hasConceptScore W2085191137C89560881 @default.
• W2085191137 hasConceptScore W2085191137C90924648 @default.
• W2085191137 hasIssue "1" @default.
• W2085191137 hasLocation W20851911371 @default.
• W2085191137 hasLocation W20851911372 @default.
• W2085191137 hasLocation W20851911373 @default.

• next